Oscar Health grew Q2 revenue and membership ~29% YoY, with rising FCF/share and cost savings driving improved margins. See why OSCR stock is a strong buy.
Wall Street Got Oscar All Wrong (NYSE:OSCR)

5
Oscar Health grew Q2 revenue and membership ~29% YoY, with rising FCF/share and cost savings driving improved margins. See why OSCR stock is a strong buy.